What will be the role of molnupiravir in the treatment of COVID-19 infection? [0.03%]
莫努匹拉韦在COVID-19感染治疗中的作用将会是什么？
Antonio Vitiello,Valentina Troiano,Raffaele La Porta
Antonio Vitiello
Knowledge of biosimilars and perceptions of the naming conventions for biosimilar products in clinical practice in the United States [0.03%]
美国临床实践中对生物类似药的认识及其命名习惯的观点
Marianna Olave,Criswell Lavery,Charles E Leonard et al.
Marianna Olave et al.
Background: Biosimilar therapies and their naming conventions are both relatively new to the drug development market and in clinical practice. We studied the use of the four-letter naming convention in practice and the kn...
Caroline Fenton,Yvette N Lamb
Caroline Fenton
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting coronavirus disease 2019 (COVID-19) pandemic has led to rapid vaccine development and emergency use (EU) rollout. Six vaccines, including tw...
Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems [0.03%]
与COVID-19疫苗相关的不良事件：加强药品警戒监测系统的必要性
Sunil Shrestha,Januka Khatri,Sujyoti Shakya et al.
Sunil Shrestha et al.
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new species of β-coronavirus genus named severe acute respiratory syndrome coronavirus 2. The COVID-19 pandemic, which started in late 2019 and continues as at mid-20...
Antonio Vitiello,Raffaele La Porta,Valentina Troiano et al.
Antonio Vitiello et al.
Lopa Thambi,Karen Konkel,Ida-Lina Diak et al.
Lopa Thambi et al.
Traveling for heart transplantation and returning with COVID-19: a logistical, clinical, and pharmacotherapeutic challenge from the Middle East [0.03%]
前往国外进行心脏移植术后返回时感染新冠肺炎：来自中东的 logistical、临床和药理挑战案例
Bassam Atallah,Iman Hamour,Saad I Mallah et al.
Bassam Atallah et al.
Heart transplantation (HT) has become a standard option for patients with end-stage heart failure (HF). However, the scarcity of donor availability remains a major hurdle for receiving this novel therapy, especially in the context of the ra...
Remdesivir in COVID-19 management: availability and relevance to low- and middle-income countries [0.03%]
论抗COVID-19药物瑞德西韦在中低收入国家的可及性和适用性
Sugat Adhikari,Sitaram Khadka,Sadhana Dahal et al.
Sugat Adhikari et al.
Self-medication during Covid-19 pandemic: challenges and opportunities [0.03%]
COVID-19大流行期间的自我药疗：挑战与机遇
Muna Malik,Muhammad Junaid Tahir,Razia Jabbar et al.
Muna Malik et al.